The effects of melatonin and Ginkgo biloba extract on memory loss and choline acetyltransferase activities in the brain of rats infused intracerebroventricularly with β-amyloid 1-40

Life Sciences

Volumn 71, Issue 22, 2002, Pages 2625-2631

  Tang, F ^a   Nag, S ^a   Shiu, S Y W ^a   Pang, S F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cholinergic; Ginkgo biloba; Melatonin; Somatostatin; Water maze

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; GINKGO BILOBA EXTRACT; MELATONIN; SOMATOSTATIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN PROTECTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; MAZE TEST; NONHUMAN; RAT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; BRAIN; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; GINKGO BILOBA; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MELATONIN; MEMORY DISORDERS; PEPTIDE FRAGMENTS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

GINKGO BILOBA;

EID: 0037131557     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02105-7     Document Type: Article

References (22)

1. Nag S., Yee B.K., Tang F. Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of β-amyloid (1-40). Brain Research Bulletin. 50:1999;251-262.
2. Nag S., Tang F. The effect of age on the response of the rat brain to continuous β-amyloid infusion. Brain Research. 889:2001;303-307.
3. Reiter R.J., Tan D.X., Qi W., Manchester L.C., Kaarbownik M., Calvo J.R. Pharmacology and Physiology of melatonin in the reduction of oxidative stress in vivo. Biological Signals and Receptors. 9:2000;160-171.
4. Tan D.X., Manchester L.C., Reiter R.J., Qi W., Kim S.J., El-Sokkay G.H. Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice. Journal of Neuroscience Research. 54:1998;382-389.
5. Behan W.M., Mcdonald M., Darlington L.G., Stone T.W. Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. British Journal of Pharmacology. 128:1999;1754-1760.
6. Chyan Y.J., Poeggeler B., Omar R.A., Chain D.G., Frangione B., Ghiso J., Pappolla M.A. Potent neuroprotective properties against Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. Journal of Biological Chemistry. 274:1999;21931-21942.
7. Maurigi C.P. Loss of intraventricular fluid melatonin can explain the neuropathology of Alzheimer's disease. Medical Hypotheses. 49:1997;153-198.
8. Dore S., Bastianetto S., Kar S., Quiron R. Protective and rescuing abilities of IGF-1 and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons. Annuals of New York Academy of Science. 890:1999;356-364.
9. Wirth S., Stemmelin J., Will B., Christen Y., Di-Scala G. Facilitative effects of EGb761 on olfactory recognition in young and aged rats. Pharmacology Biochemistry and Behaviour. 65:2000;321-326.
10. Oken B.S., Storzbach D.M., Kaye J.A. The efficacy of Gingko biloba on cognitive function in Alzheimer's disease. Archives of Neurology. 55:1998;1409-1415.
11. Wang Z.P., Man S.Y., Tang F. Age-related changes in the contents of neuropeptides in the rat brain and pituitary. Neurobiology of Aging. 14:1993;529-534.
12. Pouget B., Wellzl H., Guber M.K., Broersen L., Veenam C.L., Feldm J., Rawling J.N., Yee B.K. The effects of NMDA induced retrohippocampal lesions on performance of four spatial memory tasks known to be sensitive to hippcampal damage in the rat. European Journal of Neuroscience. 11:1999;123-140.
13. Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Research Review. 21:1996;285-300.
14. Ravel N., Chabaud P., Mannino S., Vigouroux M., Gervais R., Droix-Lefaix M.T. Ginkgo biloba extract and short-term memory. Christen Y., Droy-Lefaix M.T., Macias-Nunez J.F. Effect of Ginkgo biloba extract (EGb671) on neuronal plasticity. 1996;35-43 Elsevier, Paris.
15. Winter J.C., Timineri D. The discriminitive stimulus properties of EGB761, an extract of Ginkgo biloba. Pharmacology Biochemistry and Behaviour. 62:1999;543-547.
16. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel 1b melatonin receptor. Proceedings of National Academy of Science U.S.A. 92:1995;8734-8738.
17. Watanabe C.M., Wolffram S., Ader D., Rimbach G., Packer L., Macquire J.J., Schultz P.G., Gohil K. The in vivo neuromodulatory effects of the herbal medicine gingko biloba. Proceedings of the National Academy of Science U.S.A. 98:2001;6577-6580.
18. Gillou J.L., Micheaou J., Jafford R. The opposite effects of cysteamine on the acquisition of the different tasks in mice are associated with bidirectional testing-induced changes in hippocampal adenyl cyclase acivity. Behavioural Neuroscience. 112:1998;900-908.
19. Matsuoka N., Yamazaki M., Yamaguchi I. Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers. Neuroscience. 66:1995;616-617.
20. LeBars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schaltzberg A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA. 278:1997;1327-1332.
21. Kanowski S., Herrman W.M., Stephen K., Wierich W., Horr R. Proof of efficacy of the Ginkgo biloba special extract Egb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 294:1996;47-56.
22. Van Dongen M.C.J.M., van Rossum E., Kessels A.H., Sielhorst H.J.G.a., Knipschild P.G. The efficacy of Ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. Journal of the American Geriatric Society. 48:2000;1183-1194.